RT Journal Article
SR Electronic
A1 Vinall, Phil
T1 CORRECT Trial of Regorafenib in Metastatic Colorectal Cancer: Overall Survival Update
JF MD Conference Express
YR 2012
FD SAGE Publications
VO 12
IS 15
SP 14
OP 15
DO 10.1177/155989771215011
UL http://mdc.sagepub.com/content/12/15/14.abstract
AB There is a significant unmet clinical need for treatment options for metastatic colorectal cancer (mCRC). This article presents updated overall survival (OS) data from the Patients with Metastatic Colorectal Cancer Treated with Regorafenib or Placebo After Failure of Standard Therapy [CORRECT; NCT01103323] trial. The study demonstrated increased survival benefits following regorafenib treatment in patients with previously treated mCRC.